Company Analysis

Co-Diagnostics, Inc. (CODX)

Nasdaq: CODX · Surgical & Medical Instruments & Apparatus · Salt Lake City, UT · filing with the SEC since 2016
Grade3.5
◀ Past 3.4● Present 3.4▶ Future 3.5
1 est.

Filings

232 filings since 2017 beside 159 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 41 days after the quarter ended. The proxy statement was last filed Oct 26, 2026.

Filings a yearinsider forms included
2744393347365456
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Sep 4, 2026.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Jan 13, 2026.SEC letters: 4 in the last 36 months, the newest May 28, 2026.
Insider forms 159

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2026 10-Q Quarterly report Sep 30, 2026
Nov 10, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Nov 4, 2026 S-3 Shelf registration
Oct 26, 2026 DEF 14A Proxy statement
Oct 16, 2026 PRE 14A Preliminary proxy statement
Oct 15, 2026 8-K item 5.07 Shareholder vote · Current report Oct 14, 2026
Oct 15, 2026 8-K/A items 1.01, 2.03, 3.02, 9.01 Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report, amended Oct 9, 2026
Oct 13, 2026 8-K items 1.01, 2.03, 3.02, 9.01 Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report Oct 9, 2026
Oct 5, 2026 8-K item 5.07 Shareholder vote · Current report Sep 30, 2026
Sep 25, 2026 8-K item 5.07 Shareholder vote · Current report Sep 3, 2026
Sep 21, 2026 PRE 14A Preliminary proxy statement
Sep 16, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Sep 16, 2026 8-K items 8.01, 9.01 Other event · Current report
Sep 15, 2026 8-K item 8.01 Other event · Current report Aug 25, 2026
Sep 4, 2026 8-K item 5.02 Officer or director change · Current report Sep 2, 2026
Sep 4, 2026 DEFA14A Extra proxy material
Sep 4, 2026 8-K item 5.07 Shareholder vote · Current report Sep 3, 2026
Sep 1, 2026 EFFECT Registration effective
Aug 24, 2026 S-3 Shelf registration
Aug 14, 2026 SCHEDULE 13G Large holder notice
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 13, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Aug 10, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 31, 2026 8-K items 1.01, 3.02, 9.01 Major agreement signed; Shares sold without registration · Current report Jul 30, 2026
Jul 27, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report
Jul 27, 2026 424B5 Shelf offering
Jul 21, 2026 DEF 14A Proxy statement
Jul 10, 2026 PRE 14A Preliminary proxy statement Jul 9, 2026
Jun 3, 2026 SCHEDULE 13G Large holder notice
May 29, 2026 EFFECT Registration effective
May 28, 2026 CORRESP Reply to the SEC
May 28, 2026 S-3 Shelf registration
May 28, 2026 UPLOAD SEC comment letter
May 22, 2026 DRS Draft registration, confidential
May 21, 2026 8-K items 1.01, 3.02, 8.01, 9.01 Major agreement signed; Shares sold without registration; Other event · Current report May 19, 2026
May 15, 2026 EFFECT Registration effective
May 14, 2026 10-Q Quarterly report Mar 31, 2026
May 14, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
May 13, 2026 CORRESP Reply to the SEC
May 12, 2026 S-3 Shelf registration
40 of 232 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton CODX · research, not advice